z-logo
Premium
Exposure of bisphenol A in breast cancer patients—quantitatively assessed by sensitivity‐enhanced high‐performance liquid chromatography coupled with fluorescence detection: A case–control study
Author(s) -
Muthusamy Sivaselvakumar,
Palanisamy Susipriya,
Ramalingam Sudha
Publication year - 2021
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.5137
Subject(s) - chromatography , chemistry , analyte , high performance liquid chromatography , bisphenol a , urine , extraction (chemistry) , sample preparation , detection limit , biochemistry , organic chemistry , epoxy
A simple, reproducible and sensitive liquid chromatography (HPLC) method has been developed and validated for estimation of bisphenol A (BPA) in human urine. A simple liquid–liquid extraction technique was used in BPA sample preparation. The analyte was chromatographed on a Shimadzu Prominence HPLC system using isocratic mobile phase conditions at a flow rate of 0.500 ml/min and a Hypersil Gold C 18 column maintained at 40°C. Quantification was performed on a fluorescence detector set at excitation 275 nm, emission 313 nm and bisphenol B was used as internal standard. The total run time was 8 min. The method was found to have acceptable sensitivity, selectivity, accuracy (98.82–103.64%), precision (1.17–5.36) and stability in the validation experiment carried out as per the USFDA guidelines. The method sensitivity was as low as 0.50 ng/ml. The applicability of the validated analytical method was established in human patient urine samples. The mean human urine BPA concentrations were 1.18 ± 2.11 ng/ml in the control group and 5.76 ± 6.00 ng/ml in the patient group ( P  < 0.001). Therefore, this method could be considered as an alternative for routine bio‐monitoring of BPA which is less expensive and feasible in resource‐poor settings.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here